Harmony Biosciences Holdings Inc.(HRMY)今日盘中股价大跌18%,引发市场广泛关注。据相关消息报道,该公司近期宣布发行800万股新股,这一举措可能是导致其股价大幅波动的原因。
Harmony Biosciences是一家专注于罕见神经系统疾病治疗领域的制药公司。该公司最新财报显示营收持续增长、利润同比增加,公司业务发展保持良好态势。不过,公布发行新股的消息令投资者对其未来盈利前景表示担忧,因为发行新股会稀释现有股东的权益。
分析人士指出,发行新股一旦供给量增加,往往会对股价形成短期压力,尤其是规模较大的发行。此次发行800万股相较于现有股本规模较大,所以引发投资者抛售。不过一旦新股发行完毕、市场供需关系重新平衡,该股价格变动将趋于理性化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.